All Stories

J&J's Shockwave Medical launches path-clearing Javelin ...

While Shockwave's previous catheters emit sonic pressure waves around their circ...

Makary connects CGMs to MAHA movement at FDA confirmati...

Awaiting confirmation to become FDA commissioner, Makary also fielded questions ...

UPDATE: DOGE quietly decreases savings estimate for 30 ...

Under President Donald Trump’s administration, the DOGE has reportedly terminate...

Zymeworks pauses plans to launch one ADC into clinic in...

Zymeworks has pumped the brakes on plans to take one of its antibody-drug conjug...

Evidation elevates COO to CEO, partners with AHA

Leslie Oley Wilberforce will take the helm from co-founder Christine Lemke, who ...

Tris' next-gen pain drug completes trio of clinical win...

Tris Pharma’s opioid alternative has scored a third win in a trio of clinical tr...

Denali's ALS drug fails to redeem itself, missing key b...

Denali Therapeutics’ amyotrophic lateral sclerosis drug has racked up another cl...

Merck KGaA fails midphase lupus trial, says totality of...

One of Merck KGaA’s leading immunology assets has flunked a phase 2 lupus trial....

ITM shares details of radiopharma's phase 3 win, reveal...

ITM Isotope Technologies has provided more detail on how its lead radiotherapy b...

US judge blocks Trump administration from cutting NIH g...

A federal judge has blocked the Trump administration’s effort to slash National ...

Trump NIH nominee Jayanta Bhattacharya says he doesn't ...

President Donald Trump’s pick to lead the NIH, Jayanta Bhattacharya, M.D., Ph.D....

Trump NIH nominee Bhattacharya says he doesn’t plan on ...

President Donald Trump’s pick to lead the NIH, Jayanta Bhattacharya, M.D., Ph.D....

Amgen enters Maritime, launching 2 late-stage obesity t...

Amgen’s most advanced obesity asset MariTide is entering Maritime—that is, a pha...

Ajax, KKR launch heart failure startup with Boston Scie...

After selling its afib-focused startup to Boston Scientific earlier this year, A...

Former NIH director Francis Collins retires, calls agen...

After a 32-year career at the National Institutes of Health, Francis Collins, M....

J&J’s Shockwave Medical launches path-clearing Javelin ...

While Shockwave's previous catheters emit sonic pressure waves around their circ...

Fierce Biotech Layoff Tracker 2025: BMS cuts 57 CA jobs...

As always, if you know of layoffs occurring at a biotech, please reach out to th...

ALX lays off 30% of staff to pay for more trials of CD4...

ALX Oncology is laying off 30% of its workforce as the biotech seeks to channel ...

NIH cancels some grants for LGBTQ+ health research effe...

Several scientists studying LGBTQ+ health issues have had their grants from the ...

NIH cancels some grants for LGBTQ+ health research effe...

Several scientists studying LGBTQ+ health issues have had their grants from the ...

Jazz hands over $935M to buy Chimerix for near-approval...

Jazz Pharmaceuticals has drummed up a deal in double time, agreeing to buy Chime...

Celon's PDE10A inhibitor reduces involuntary movements ...

Celon Pharma’s PDE10A inhibitor has reduced involuntary movements in a phase 2 t...

Acelyrin doubles down on Alumis merger after deciding C...

Acelyrin consulted with independent advisors and came to the conclusion that the...

NIH cancels grants for LGBTQ+ health research effective...

Several scientists studying LGBTQ+ health issues have had their grants from the ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.